| Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality DA Ross, N Dollimore, PG Smith, BR Kirkwood, P Arthur, SS Morris, ... The Lancet 342 (8862), 7-12, 1993 | 379 | 1993 |
| The political origins of health inequity: prospects for change OP Ottersen, J Dasgupta, C Blouin, P Buss, V Chongsuvivatwong, J Frenk, ... The Lancet 383 (9917), 630-667, 2014 | 377 | 2014 |
| Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study MY Osei-Atweneboana, JKL Eng, DA Boakye, JO Gyapong, RK Prichard The Lancet 369 (9578), 2021-2029, 2007 | 330 | 2007 |
| Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11. 2 T Thye, FO Vannberg, SH Wong, E Owusu-Dabo, I Osei, J Gyapong, ... Nature genetics 42 (9), 739, 2010 | 317 | 2010 |
| Autophagy gene variant IRGM− 261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains CD Intemann, T Thye, S Niemann, ENL Browne, MA Chinbuah, A Enimil, ... PLoS pathogens 5 (9), e1000577, 2009 | 209 | 2009 |
| Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus MY Osei-Atweneboana, K Awadzi, SK Attah, DA Boakye, JO Gyapong, ... PLoS neglected tropical diseases 5 (3), e998, 2011 | 208 | 2011 |
| Influence of morbidity on serum retinol of children in a community-based study in northern Ghana SM Filteau, SS Morris, RA Abbott, AM Tomkins, BR Kirkwood, P Arthur, ... The American journal of clinical nutrition 58 (2), 192-197, 1993 | 206 | 1993 |
| Treatment strategies underpinning the global programme to eliminate lymphatic filariasis JO Gyapong, V Kumaraswami, G Biswas, EA Ottesen Expert opinion on pharmacotherapy 6 (2), 179-200, 2005 | 198 | 2005 |
| Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial MF Gomes, MA Faiz, JO Gyapong, M Warsame, T Agbenyega, A Babiker, ... The Lancet 373 (9663), 557-566, 2009 | 173 | 2009 |
| Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana EK Ansah, S Narh-Bana, M Epokor, S Akanpigbiam, AA Quartey, ... Bmj 340, c930, 2010 | 170 | 2010 |
| Common variants at 11p13 are associated with susceptibility to tuberculosis T Thye, E Owusu-Dabo, FO Vannberg, R van Crevel, J Curtis, ... Nature genetics 44 (3), 257, 2012 | 156 | 2012 |
| Improving adherence to malaria treatment for children: the use of pre‐packed chloroquine tablets vs. chloroquine syrup EK Ansah, JO Gyapong, IA Agyepong, DB Evans Tropical Medicine & International Health 6 (7), 496-504, 2001 | 147 | 2001 |
| Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa S Brooker, NB Kabatereine, JO Gyapong, JR Stothard, J Utzinger Parasitology 136 (13), 1707-1718, 2009 | 145 | 2009 |
| Effect of removing direct payment for health care on utilisation and health outcomes in Ghanaian children: a randomised controlled trial EK Ansah, S Narh-Bana, S Asiamah, V Dzordzordzi, K Biantey, K Dickson, ... PLoS medicine 6 (1), e1000007, 2009 | 138 | 2009 |
| The epidemiology of obesity in Ghana RB Biritwum, J Gyapong, G Mensah Ghana medical journal 39 (3), 82, 2005 | 138 | 2005 |
| Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities JO Gyapong, M Gyapong, N Yellu, K Anakwah, G Amofah, M Bockarie, ... The Lancet 375 (9709), 160-165, 2010 | 119 | 2010 |
| Progressivity of health care financing and incidence of service benefits in Ghana J Akazili, B Garshong, M Aikins, J Gyapong, D McIntyre Health policy and planning 27 (suppl_1), i13-i22, 2012 | 108 | 2012 |
| Epidemiology of malaria in the forest-savanna transitional zone of Ghana S Owusu-Agyei, KP Asante, M Adjuik, G Adjei, E Awini, M Adams, ... Malaria Journal 8 (1), 220, 2009 | 107 | 2009 |
| An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis J Horton, C Witt, EA Ottesen, JK Lazdins, DG Addiss, K Awadzi, MJ Beach, ... Parasitology 121 (S1), S147-S160, 2000 | 107 | 2000 |
| Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment K Yeboah-Antwi, JO Gyapong, IK Asare, G Barnish, DB Evans, S Adjei Bulletin of the World Health Organization 79, 394-399, 2001 | 105 | 2001 |
